| 000 | 01626 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515025404.0 | ||
| 264 | 0 | _c20080108 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0300-8126 | ||
| 024 | 7 |
_a10.1007/s15010-006-4114-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenshke-Bar-Meir, R | |
| 245 | 0 | 0 |
_aAssessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae. _h[electronic resource] |
| 260 |
_bInfection _cApr 2006 |
||
| 300 |
_a66-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 | _aCephalosporin Resistance |
| 650 | 0 | 4 |
_aCephalosporins _xpharmacology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aEnterobacteriaceae _xclassification |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHospital Mortality |
| 650 | 0 | 4 | _aHospitals, University |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsrael |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_abeta-Lactamases _xbiosynthesis |
| 700 | 1 | _aYinnon, A M | |
| 700 | 1 | _aRudensky, B | |
| 700 | 1 | _aAttias, D | |
| 700 | 1 | _aSchlesinger, Y | |
| 700 | 1 | _aRaveh, D | |
| 773 | 0 |
_tInfection _gvol. 34 _gno. 2 _gp. 66-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s15010-006-4114-z _zAvailable from publisher's website |
| 999 |
_c16302912 _d16302912 |
||